Anti-TCIM/ C8orf4/ TC-1 monoclonal antibody

Anti-TCIM/ C8orf4/ TC-1 antibody for FACS & in-vivo assay

Target products collectionGo to TCIM/TCIM products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2351-Ab-1/ GM-Tg-hg-MP2351-Ab-2Anti-Human TCIM monoclonal antibodyHuman
GM-Tg-rg-MP2351-Ab-1/ GM-Tg-rg-MP2351-Ab-2Anti-Rat TCIM monoclonal antibodyRat
GM-Tg-mg-MP2351-Ab-1/ GM-Tg-mg-MP2351-Ab-2Anti-Mouse TCIM monoclonal antibodyMouse
GM-Tg-cynog-MP2351-Ab-1/ GM-Tg-cynog-MP2351-Ab-2Anti-Cynomolgus/ Rhesus macaque TCIM monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2351-Ab-1/ GM-Tg-felg-MP2351-Ab-2Anti-Feline TCIM monoclonal antibodyFeline
GM-Tg-cang-MP2351-Ab-1/ GM-Tg-cang-MP2351-Ab-2Anti-Canine TCIM monoclonal antibodyCanine
GM-Tg-bovg-MP2351-Ab-1/ GM-Tg-bovg-MP2351-Ab-2Anti-Bovine TCIM monoclonal antibodyBovine
GM-Tg-equg-MP2351-Ab-1/ GM-Tg-equg-MP2351-Ab-2Anti-Equine TCIM monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2351-Ab-1/ GM-Tg-hg-MP2351-Ab-2; GM-Tg-rg-MP2351-Ab-1/ GM-Tg-rg-MP2351-Ab-2;
GM-Tg-mg-MP2351-Ab-1/ GM-Tg-mg-MP2351-Ab-2; GM-Tg-cynog-MP2351-Ab-1/ GM-Tg-cynog-MP2351-Ab-2;
GM-Tg-felg-MP2351-Ab-1/ GM-Tg-felg-MP2351-Ab-2; GM-Tg-cang-MP2351-Ab-1/ GM-Tg-cang-MP2351-Ab-2;
GM-Tg-bovg-MP2351-Ab-1/ GM-Tg-bovg-MP2351-Ab-2; GM-Tg-equg-MP2351-Ab-1/ GM-Tg-equg-MP2351-Ab-2
Products NameAnti-TCIM monoclonal antibody
Formatmab
Target NameTCIM
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TCIM benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TCIM/ C8orf4/ TC-1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2351
    Target NameTCIM
    Gene ID56892,69068,684871,702517,607623,101084103,617047,100050602
    Gene Symbol and Synonyms1110065B09Rik,1810011O10Rik,C16H8orf4,C27H8orf4,C8H8orf4,C8orf4,CB1H8orf4,TC-1,TC1,TCIM
    Uniprot AccessionQ9NR00,Q5E969
    Uniprot Entry NameTCIM_HUMAN,TCIM_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176907
    Target ClassificationN/A

    The target: TCIM, gene name: TCIM, also named as C8orf4, TC-1, TC1. This gene encodes a small, monomeric, predominantly unstructured protein that functions as a positive regulator of the Wnt/beta-catenin signaling pathway. This protein interacts with a repressor of beta-catenin mediated transcription at nuclear speckles. It is thought to competitively block interactions of the repressor with beta-catenin, resulting in up-regulation of beta-catenin target genes. The encoded protein may also play a role in the NF-kappaB and ERK1/2 signaling pathways. Expression of this gene may play a role in the proliferation of several types of cancer including thyroid cancer, breast cancer and hematological malignancies. [provided by RefSeq, Nov 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.